Navigation Links
5 Washington organizations make joint grant
Date:9/7/2013

SEATTLE, Washington, September 5, 2013 A product development team at the University of Washington (UW) will receive $390,000 from five organizations dedicated to fostering technology commercialization in Washington.

The grant will support refinement and clinical testing of a handheld device to improve treatment of trauma, which is the leading cause of death for people under age 45. Trauma patients often die from excessive bleeding; blood loss can be worsened by a hard-to-diagnose condition called trauma-induced coagulopathy (TIC). A team led by Nathan Sniadecki in the UW Department of Mechanical Engineering and Nathan White in the UW Department of Medicine, Division of Emergency Medicine, is developing a tool to rapidly detect TIC and thus permit immediate and appropriate treatment of this life-threatening condition. The device will measure the ability of the blood to clot during trauma, which can take up to half an hour to detect with current technology. The team has also formed a company, Stasys, to license the technology and bring the product to market.

This grant is funded by the Coulter Translational Research Partnership Program at UW, the Life Sciences Discovery Fund (LSDF), the Institute of Translational Health Sciences, the UW Center for Commercialization (C4C), and the Washington Research Foundation.

"Each of our organizations actively funds research and development in Washington to help move promising technologies from the academic into the commercial environment," explained Patrick Shelby, director of New Ventures at C4C.

"There has been substantial overlap in the projects that we support, with several projects receiving funding from all five programs serially for different work plans. This grant is based on our belief that joint funding for a single work plan will drive faster and more efficient commercial development than serial funding."

The TIC detection device project was reviewed by external experts for scientific and technical merit, commercial potential, and possible health and economic benefits.

Shelby expressed his desire that based on the success of this initial award, the funding organizations would consider collaborating in funding future grants. John DesRosier, executive director of LSDF, further noted that this was the first time LSDF had partnered with other granting entities and stated that he hoped that this model could be replicated with other Washington universities and institutions.


'/>"/>

Contact: Cathyryne Manner
manner@lsdfa.org
206-456-9583
Life Sciences Discovery Fund
Source:Eurekalert

Related biology technology :

1. SoundConnect Announces Expansion into New York City and Washington D.C.
2. BioLife Solutions Named One of Washingtons Best Companies
3. Douglas Harrington, MD Speaks At American Academy Of Physicians Assistants 2013 Conference In Washington, DC
4. Washington State University to Present on Tin Nanoneedles: A Technology for Lithium-ion Batteries, at Knowledge Foundation’s Next Generation Batteries 2013 Conference
5. New Strain of Bacteria May Clear up Acne Probiotic Action Explains the New Research Findings from Washington University
6. Bed Bugs Find Their Way to University of Washington and Hastings-on-Hudson Libraries; Bed Bug Control 911 Advises Use of Bed Bug Spray to Effectively Clear the Pests Away
7. EcoSolutions Prevents Flooding in Washington D.C.
8. Biodetection 2012 Conference Brings Together Leading Organizations from Around the World to Address Challenges & Technology Advances in Detection and Identification of Biological Threats in Washington, DC from June 28-29, 2012
9. National Defense Industrial Association (NDIA) Opens Registration For 2012 Biosurveillance Conference, Set For August 27-28 in Washington, D.C.
10. CMC Biologics Honored as Finalist for Washingtons Manufacturing Company of the Year Award
11. Core and More Technologies Helps Organizations Migrate to Google’s Enhanced Campaign Structure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... Calif. , Dec. 2, 2016 Amgen (NASDAQ: ... AGN ) today announced the submission of a Marketing Authorization ... 215, a biosimilar candidate to Avastin ® (bevacizumab). The ... submitted to the EMA. "The submission of ... Amgen seeks to expand our oncology portfolio," said Sean ...
(Date:12/2/2016)... ... December 01, 2016 , ... ACEA Biosciences, Inc. announced ... I/II clinical trials for AC0010 at the World Conference on Lung Cancer 2016, taking ... update on the phase I/II clinical trials for AC0010 in patients with advanced non-small ...
(Date:12/2/2016)... (PRWEB) , ... December 01, 2016 , ... ... Computational Science Symposium (CSS) and the popularity of US Single Day Events (SDE) ... place in early Summer 2018, in Raleigh, NC. Topics of the pharmaceutical and ...
(Date:12/2/2016)... ... December 01, 2016 , ... Orthogonal, a ... their recent FDA Class II 510(k) clearance for their flagship medical device, SimplECG. ... remote cardiac monitoring devices that rely on cloth-based nanosensors. While other companies have ...
Breaking Biology Technology:
(Date:6/21/2016)... June 21, 2016 NuData Security announced today ... role of principal product architect and that ... of customer development. Both will report directly to ... The moves reflect NuData,s strategic growth in its ... high customer demand and customer focus values. ...
(Date:6/15/2016)... 15, 2016 Transparency Market ... Recognition Market by Application Market - Global Industry Analysis Size ... to the report, the  global gesture recognition market ... and is estimated to grow at a CAGR ... 2024.  Increasing application of gesture recognition ...
(Date:6/7/2016)... -- Syngrafii Inc. and San Antonio Credit Union (SACU) ... Syngrafii,s patented LongPen™ eSignature "Wet" solution into SACU,s ... in greater convenience for SACU members and operational ... document workflow and compliance requirements. Logo ... Highlights: ...
Breaking Biology News(10 mins):